OrbiMed’s Oric Pharmaceuticals ORIC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $9.13M | Buy |
|
|||||
|
2025
Q1 | $3.91M | Buy |
|
|||||
|
2024
Q3 | – | Sell |
|
|||||
|
2024
Q2 | $2.03M | Hold |
|
|||||
|
2024
Q1 | $3.95M | Sell |
|
|||||
|
2023
Q4 | $4.81M | Sell |
|
|||||
|
2023
Q3 | $5.41M | Sell |
|
|||||
|
2023
Q2 | $9.07M | Sell |
|
|||||
|
2023
Q1 | $7.83M | Sell |
|
|||||
|
2022
Q4 | $9.47M | Sell |
|
|||||
|
2022
Q3 | $6.68K | Hold |
|
|||||
|
2022
Q2 | $9.35K | Hold |
|
|||||
|
2022
Q1 | $11.1M | Sell |
|
|||||
|
2021
Q4 | $34.4M | Hold |
|
|||||
|
2021
Q3 | $48.9M | Hold |
|
|||||
|
2021
Q2 | $41.4M | Hold |
|
|||||
|
2021
Q1 | $57.3M | Sell |
|
|||||
|
2020
Q4 | $98.9M | Hold |
|
|||||
|
2020
Q3 | $73.1M | Hold |
|
|||||
|
2020
Q2 | $98.6M | Buy |
|